NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / World News / Chinese cat owners are feeding COVID-19 pills to pets
    Next Article
    Chinese cat owners are feeding COVID-19 pills to pets
    Lagevrio is not approved for use in animals

    Chinese cat owners are feeding COVID-19 pills to pets

    By Chanshimla Varah
    Jan 04, 2025
    03:22 pm

    What's the story

    Cat owners in China have started using Merck & Co's COVID-19 antiviral pills, Lagevrio, to treat feline infectious peritonitis (FIP), a fatal disease caused by a feline coronavirus.

    The trend has caught on on social media platforms such as Xiaohongshu, China's version of Instagram.

    Users are posting their experiences and tips on using these drugs to save their pets and reduce veterinary costs, Bloomberg reported.

    Cost-effective treatment

    Pet owners turn to affordable human antivirals

    One Xiaohongshu user wrote, "COVID-19 drugs for humans saved my cat's life."

    Apart from Merck's Lagevrio, some pet owners are also choosing cheaper COVID-19 medicines from Chinese firms Henan Genuine Biotech and Simcere Pharmaceutical Group.

    Lagevrio's 40-pill bottle costs around 1,725 yuan (S$320) online and can be used to treat several cats, making it more affordable than earlier treatments.

    Treatment accessibility

    FIP treatment challenges and cost concerns

    FIP is a cat-only disease and not transmissible to other species.

    Before human COVID-19 antivirals became available, the antiviral GS-441524 proved effective against FIP but was hard to obtain legally.

    Chinese cat owners often turned to black market suppliers for GS-441524, which could cost tens of thousands of yuan.

    The medications are GS-441524 knockoffs often manufactured by a variety of Chinese businesses.

    HMPV

    Surge in HMPV cases 

    The report comes amid a surge in human metapneumovirus (HMPV) cases in China.

    The virus, which mainly affects children, the elderly, and immunocompromised people, has been spreading rapidly in northern China.

    It causes common cold-like symptoms, including cough, fever, nasal congestion, and wheezing. In severe cases, it may cause bronchitis and pneumonia.

    Unlike COVID-19 and the flu, there is no vaccine for HMPV at present.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    China
    Instagram

    Latest

    Is Matt Reeves not returning for 'The Batman 2'?  James Gunn
    This AI uses selfies to predict cancer survival chances Artificial Intelligence and Machine Learning
    'Nothing greater than nation': BCCI secretary amid IPL 2025 suspension  Indian Premier League (IPL)
    Meet SkyStriker, made-in-Bengaluru suicide drones deployed in Operation Sindoor Bengaluru

    China

    China's new iron-making method increases productivity by 3,600 times Technology
    China shifts monetary policy stance for first time since 2011 Donald Trump
    China probes NVIDIA for alleged anti-monopoly law violations NVIDIA
    Trump mocks 'governor' Trudeau, says Canada should become 51st state  Canada

    Instagram

    How to create a non-profit fundraiser on Instagram Technology
    How to donate to a non-profit fundraiser on Instagram Technology
    Instagram now lets you schedule direct messages: Here's how Technology
    How to create your 2024 recap collage on Instagram Instagram Stories
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025